Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Leukemia
|
March 31, 1998
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B
E J Lee, S L George, P C Amrein, et al.
Journal of the National Cancer Institute
|
April 6, 1988
Intensive single-agent mitoxantrone for metastatic breast cancer
E J Shpall, R B Jones, J F Holland, et al.
Cancer Treatment Reviews
|
June 1, 1989
Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
P A Paciucci, J F Holland, J S Ryder, et al.
Immunology Letters
|
December 1, 1988
Pinocchio cells: morphologically atypical immunologically heterogeneous lymphocytes induced by treatment with interleukin 2
P A Paciucci, P G Chesa, M T Fierro, et al.
Cancer Investigation
|
January 1, 1991
Chemotherapy of metastatic Merkel cell cancer
J Crown, R Lipzstein, S Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Surgical treatment of spinal cord compression from epidural metastasis
N Sundaresan, V P Sachdev, J F Holland, et al.
Leukemia
|
May 1, 1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study
J Cuttner, R Mick, D R Budman, et al.
Journal of Biological Response Modifiers
|
August 1, 1989
Systemic biodistribution of radioiodinated interleukin-2 in the rat
R Gennuso, M K Spigelman, S Vallabhajosula, et al.
The New England Journal of Medicine
|
June 22, 1995
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B
R M Stone, D T Berg, S L George, et al.
Blood
|
July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
R M Stone, D T Berg, S L George, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Leukemia
|
March 31, 1998
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B
E J Lee, S L George, P C Amrein, et al.
Journal of the National Cancer Institute
|
April 6, 1988
Intensive single-agent mitoxantrone for metastatic breast cancer
E J Shpall, R B Jones, J F Holland, et al.
Cancer Treatment Reviews
|
June 1, 1989
Immunotherapy with interleukin-2 by constant infusion with and without adoptive cell transfer and with weekly doxorubicin
P A Paciucci, J F Holland, J S Ryder, et al.
Immunology Letters
|
December 1, 1988
Pinocchio cells: morphologically atypical immunologically heterogeneous lymphocytes induced by treatment with interleukin 2
P A Paciucci, P G Chesa, M T Fierro, et al.
Cancer Investigation
|
January 1, 1991
Chemotherapy of metastatic Merkel cell cancer
J Crown, R Lipzstein, S Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Surgical treatment of spinal cord compression from epidural metastasis
N Sundaresan, V P Sachdev, J F Holland, et al.
Leukemia
|
May 1, 1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study
J Cuttner, R Mick, D R Budman, et al.
Journal of Biological Response Modifiers
|
August 1, 1989
Systemic biodistribution of radioiodinated interleukin-2 in the rat
R Gennuso, M K Spigelman, S Vallabhajosula, et al.
The New England Journal of Medicine
|
June 22, 1995
Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B
R M Stone, D T Berg, S L George, et al.
Blood
|
July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
R M Stone, D T Berg, S L George, et al.
Page
of 4